CORDIS
EU research results

CORDIS

English EN

A system view on the differential activities of human type I interferons

Project information

Grant agreement ID: 223608

Status

Closed project

  • Start date

    1 January 2009

  • End date

    31 December 2012

Funded under:

FP7-HEALTH

  • Overall budget:

    € 3 761 194

  • EU contribution

    € 2 866 405

Coordinated by:

UNIVERSITAET OSNABRUECK

Germany

Objective

Type I interferons (IFNs) form a restricted network of highly related immune cytokines that elicit differential biological responses through a single cell surface receptor comprised of the subunits IFNAR1 and IFNAR2. We have shown that differential signal activation correlates with differential interaction and conformational dynamics of the receptor induced by binding of different member of the IFN family. The goal of this project is to employ a systems biology approach to identify the molecular and cellular mechanisms responsible for translating receptor dynamics into differential cellular responses by combining biochemical, biophysical and genetic analysis of the signaling outputs. We will collect quantitative data describing type I interferon signaling from ligand recognition until phenomenological cellular responses in a number of well defined cell lines. Based on detailed structure functions studies, we will generate a set of IFN mutants with highly differential cellular responses. Based on this sub-family of ligands, we will explore the molecular and cellular dynamics of the signaling complex on the plasma membrane, as well as the receptor trafficking upon activation. Moreover, we will analyze the protein-protein interaction network involved in signal transduction and obtain a spatio-temporal picture of key signaling pathways. These studies will be flanked by extensive analyses of gene transcription levels and correlated with cellular responses. Using these data sets, input and output signals will be correlated on different levels by various mathematical approaches to understand how the processing of differential input signals is translated within the cell to produce different responses to binding the same surface receptors. In order to test the validity of these models, experimental and theoretical studies will be tightly coupled, for example, in designing network perturbations. As a proof-of-concept for this approach, we will design IFNs with optimized potencies for medical application, such as the ex vivo differentiation of monocytes into dendritic cell for application as cancer vaccines.

Coordinator

UNIVERSITAET OSNABRUECK

Address

Neuer Graben/Schloss 29
49074 Osnabrueck

Germany

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 773 560

Administrative Contact

Renate Sokolowski (Ms.)

Participants (4)

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

France

EU Contribution

€ 570 977

WEIZMANN INSTITUTE OF SCIENCE

Israel

EU Contribution

€ 540 180

INSTITUT PASTEUR

France

EU Contribution

€ 472 000

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

Switzerland

EU Contribution

€ 509 688

Project information

Grant agreement ID: 223608

Status

Closed project

  • Start date

    1 January 2009

  • End date

    31 December 2012

Funded under:

FP7-HEALTH

  • Overall budget:

    € 3 761 194

  • EU contribution

    € 2 866 405

Coordinated by:

UNIVERSITAET OSNABRUECK

Germany

This project is featured in...